Thermochemotherapy of a human salivary adenocarcinoma cell line

Oncology Reports

Volumn 9, Issue 2, 2002, Pages 365-369

  Asaumi, Jun Ichi ^a   Higuchi, Yuzuru ^a   Matsuzaki, Hidenobu ^a   Murakami, Jun ^a   Kawasaki, Shoji ^b   Kuroda, Masahiro ^b   Shibuya, Koichi ^b   Konouchi, Hironobu ^a   Hisatomi, Miki ^a   Wakasa, Toru ^a   Kishi, Kanji ^a   Hiraki, Yoshio ^b  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Adenocarcinoma; Oral cancer; Salivary gland tumor; Thermochemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; DOXORUBICIN; FLUOROURACIL; MITOMYCIN;

ADENOCARCINOMA; ARTICLE; CELL CULTURE; CELL SURVIVAL; DRUG EFFECT; HUMAN; HYPERTHERMIC THERAPY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; SALIVARY GLAND TUMOR;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; BLEOMYCIN; CELL SURVIVAL; CISPLATIN; COMBINED MODALITY THERAPY; DOXORUBICIN; FLUOROURACIL; HUMANS; HYPERTHERMIA, INDUCED; MITOMYCIN; SALIVARY GLAND NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0036515157     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.9.2.365     Document Type: Article

References (22)

1. Sipro RH: Management of malignant tumors of the salivary glands. Oncology 12: 671-680, 1998.
2. Sakata K, Aoki Y, Karasawa K, Nakagawa K, Hasezawa K, Muta N, Terahara A, Onogi Y, Sasaki Y, Akanuma A, et al: Radiation therapy for patients of malignant salivary gland tumors with positive surgical margins. Strahlenther Onkol 170: 342-346, 1994. (Pubitemid 24203257)
3. Barnett TA, Kapp DS and Goffinet DR: Adenoid cystic carcinoma of the salivary glands: management of recurrent, advanced, or persistent disease with hyperthermia and radiation therapy. Cancer 65: 2648-5266, 1990.
4. Chou C, Zhu G, Luo M and Xue G: Carcinoma of the minor salivary glands: results of surgery and combined therapy. J Oral Maxillofac Surg 54: 448-453, 1996. (Pubitemid 26105607)
5. Alberts DS, Manning MR, Coulthard SW, Koopmann CF Jr and Herman TS: Adriamycin/cisplatinum/cyclophosphamide combination chemotherapy for advanced carcinoma of the parotid gland. Cancer 47: 645-648, 1981.
6. Hill ME, Constenla DO, A'Hern RP, Henk JM, Rhys-Evans P, Breach N, Archer D and Gore ME: Cisplatin and 5-fluorouracil for symptom control in advanced salivary adenoid cystic carcinoma. Oral Oncol 33: 275-278, 1997.
7. Licitra L, Cavina R, Grandi C, Palma SD, Guzzo M, Demicheli R and Molinari R: Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma. A phase II trial of 22 patients. Ann Oncol 7: 640-642, 1996. (Pubitemid 26285647)
8. Airoldi M, Fornari G, Pedani F, Marchionatti S, Gabriele P, Succo G and Bumma C: Paclitaxel and carboplatin for recurrent salivary gland malignancies. Anticancer Res 20: 3781-3783, 2000. (Pubitemid 32002275)
9. Goldobenko GV, Liubaev VL, Tkachev SI and Amraliev NM: The thermoradiotherapy of malignant salivary gland tumors. Med Radiol 36: 7-9, 1991.
10. Shirasuna K, Sato M and Miyazaki T: A neoplastic epithelial duct cell line established from an irradiated human salivary gland. Cancer 48: 745-752, 1981. (Pubitemid 11075229)
11. Shirasuna K, Watatani K, Sugiyama M, Morioka S and Miyazaki T: Isolation and characterization of different clones including myoepithelial-like variants from a clonal neoplastic epithelial duct cell line of human salivary gland origin. Cancer Res 46: 1418-1426, 1986. (Pubitemid 16048290)
12. Bauer KD and Henle KJ: Arrhenius analysis of heat survival curves from normal and thermotolerant CHO cells. Radiat Res 78: 251-263, 1979. (Pubitemid 9176284)
13. Asaumi J, Kawasaki S, Kuroda M, Takeda Y and Hiraki Y: Thermosensitivity and thermotolerance in the adriamycin-resistant strain of Ehrlich ascites tumor cells. Anticancer Res 16: 2569-2573, 1996. (Pubitemid 26388219)
14. Urano M, Kuroda M and Nishimura Y: For the clinical application of thermochemotherapy given at mild temperatures. Int J Hyperthermia 15: 79-107, 1999. (Pubitemid 29149801)
15. Kawasaki S, Asaumi J, Shibuya K, Kuroda M and Hiraki Y: Recent aspect of educidating the cellular basis of thermochemotherapy. In: Thermotherapy for Neoplasia, Inflammation, and Pain. Kosaka M, Sugahara T, Scmidt KL and Simon E (eds). Springer-Verlag, Tokyo, pp424-432, 2001.
16. Nagaoka S, Kawasaki S, Karino Y, Sasaki K and Nakanishi T: Modification of cellular efflux and cytotoxicity of adriamycin by biscoclaulin alkaloid in vitro. Eur J Cancer Clin Oncol 23: 1297-1302, 1987. (Pubitemid 18006719)
17. Asaumi J, Kawasaki S, Nishikawa K, Kuroda M and Hiraki Y: Effects of hyperthermia and cepharanthin on adriamycin accumulation with changes in extracellular pH. Int J Hyperthermia 11: 27-35, 1995.
18. Urano M, Kahn J and Kenton LA: The effect of cis- diamminedichloroplatinum(II) treatment at elevated temperatures on murine fibrosarcoma, FSa-II. Int J Hyperthermia 6: 563-570, 1990. (Pubitemid 20238381)
19. Sakamoto Y, Yui S, Tsuyama Y and Akagawa T: Studies on antitumor effect and intratumor concentrations of thermochemotherapy using cis- diamminedichloroplatinum(II). Jpn J Oral Maxillofac Surg 39: 23-30, 1993.
20. Ohtsubo T, Chang SW, Tsuji K, Picha P, Saito H and Kano E: Effects of cis-diamminedichloroplatinum (CDDP) and cis-diammine (1,1- cyclobutanedicarboxylate) platinum (CBDCA) on thermotolerance development and thermosensitivity of the thermotolerant cells. Int J Hyperthermia 6: 1031-1039, 1990. (Pubitemid 20366026)
21. Ohtsubo T, Saito H, Matsumoto H, Hayashi S, Shioura H, Kitai R, Saito T and Kano E: In vitro effects of hyperthermia combined with cisplatin or peplomycin on the human maxillary carcinoma cell line IMC-2. Int J Hyperthermia 13: 59-67, 1997. (Pubitemid 27065001)
22. Hahn GM, Braun J and Har-Kedar I: Thermochemotherapy: synergism between hyperthermia (42-43 degrees) and adriamycin (of bleomycin) in mammalian cell inactivation. Proc Natl Acad Sci USA 72: 937-940, 1975.